Nuclivision
Founded 2022 · 19 employees on LinkedIn · 2 known investors
NucliVision develops technology for nuclear medicine departments to address capacity constraints amid rising demand in theranostics, neurology, and cardiology. Its offering targets the clinical, operational, and financial challenges hospitals face, such as long waiting lists and tracer costs.
Investors · 2
Funding
SEC filings, press & company announcements$5.5M disclosed across 1 round · 2025
- $5.5MraisedApr 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nuclivision do?
- NucliVision develops technology for nuclear medicine departments to address capacity constraints amid rising demand in theranostics, neurology, and cardiology. Its offering targets the clinical, operational, and financial challenges hospitals face, such as long waiting lists and tracer costs.
- Who are Nuclivision's investors?
- Nuclivision's investors include Heran Partners, imec.istart.
- How much funding has Nuclivision raised?
- Nuclivision has disclosed $5.5M raised across 1 round.